While I'm grateful CytoDyn is making their news and information known to the shareholder/business community, I believe the reason they may not yet be getting their case before the general public is because it's not going out to the 'general' media with press releases. For example, even when it is in the " Associated Press " newswire, the information AP gets is from the business wire CytoDyn subscribes to which is Globe Newswire :

All the reports emanate from Globe Newswire which CytoDyn pays for:

Quote:

---

PRESS RELEASE: Paid content from Globe Newswire

---

https://apnews.com/05d743130fac515095242deb6dba6d6d

Quote:

---

PRESS RELEASE: Paid content

---

https://apnews.com/481f421c1db7fd566ee5ce647c7333d5


I believe it's via this publicity that Dr. Pourhassan was called by more than 70 hospital and other medical facilities, etc.

Maybe CytoDyn would be bombarded if the regular, mainstream media got wind of Leronlimab ... nice problem to have I suppose.